Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2023
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
437
+1.5%
|
-
|
|
Sep 28
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
831
-0.2%
|
$11,634
$14.16 P/Share
|
|
Sep 28
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
568
-0.45%
|
$7,952
$14.16 P/Share
|
|
Sep 28
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
659
-0.24%
|
$9,226
$14.16 P/Share
|
|
Sep 28
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
464
-0.39%
|
$6,496
$14.16 P/Share
|
|
Sep 24
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
290
+0.07%
|
-
|
|
Sep 24
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
260
+0.21%
|
-
|
|
Sep 24
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
290
+0.43%
|
-
|
|
Sep 24
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
802
+0.29%
|
-
|
|
Sep 24
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
221
+0.37%
|
-
|
|
Sep 21
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
539
-0.81%
|
$6,468
$12.7 P/Share
|
|
Sep 10
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
330
+0.26%
|
-
|
|
Sep 10
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
1,022
+0.24%
|
-
|
|
Sep 10
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
792
+0.29%
|
-
|
|
Sep 10
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
408
+0.61%
|
-
|
|
Sep 10
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
328
+0.56%
|
-
|
|
Aug 27
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
403
+0.32%
|
-
|
|
Aug 27
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
1,248
+0.3%
|
-
|
|
Aug 27
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
966
+0.35%
|
-
|
|
Aug 27
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
498
+0.74%
|
-
|
|
Aug 27
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
401
+0.68%
|
-
|
|
Aug 25
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
347
-0.29%
|
$3,470
$10.99 P/Share
|
|
Aug 25
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
585
-0.88%
|
$5,850
$10.99 P/Share
|
|
Aug 25
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
410
-0.33%
|
$4,100
$10.99 P/Share
|
|
Aug 25
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
1,729
-0.41%
|
$17,290
$10.99 P/Share
|
|
Aug 25
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
519
-0.19%
|
$5,190
$10.99 P/Share
|
|
Aug 25
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
347
-0.82%
|
$3,470
$10.99 P/Share
|
|
Aug 25
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
347
-0.79%
|
$3,470
$10.99 P/Share
|
|
Aug 25
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
179
-0.31%
|
$1,790
$10.99 P/Share
|
|
Aug 14
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
277
-0.07%
|
$3,324
$12.38 P/Share
|
|
Aug 14
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
104
-0.24%
|
$1,248
$12.38 P/Share
|
|
Aug 14
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
156
-0.12%
|
$1,872
$12.38 P/Share
|
|
Aug 14
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
94
-0.14%
|
$1,128
$12.57 P/Share
|
|
Aug 14
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
109
-0.19%
|
$1,308
$12.57 P/Share
|
|
Aug 14
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
134
-0.11%
|
$1,608
$12.38 P/Share
|
|
Aug 14
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
180
-0.07%
|
$2,160
$12.38 P/Share
|
|
Aug 14
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
108
-0.25%
|
$1,296
$12.38 P/Share
|
|
Aug 09
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
58,465
+0.76%
|
$760,045
$13.2 P/Share
|
|
Jul 24
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
462
-1.04%
|
$8,778
$19.5 P/Share
|
|
Jul 24
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
679
-1.57%
|
$12,901
$19.5 P/Share
|
|
Jul 20
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.55%
|
$200,000
$20.07 P/Share
|
|
Jul 20
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.43%
|
$20,000
$2.06 P/Share
|
|
Jul 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.55%
|
$200,000
$20.46 P/Share
|
|
Jul 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.43%
|
$20,000
$2.06 P/Share
|
|
Jul 11
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
331
-0.76%
|
$7,282
$22.79 P/Share
|
|
Jun 27
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
877
-0.21%
|
$19,294
$22.91 P/Share
|
|
Jun 27
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
489
-0.41%
|
$10,758
$22.91 P/Share
|
|
Jun 27
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
590
-0.47%
|
$12,980
$22.91 P/Share
|
|
Jun 27
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
695
-0.25%
|
$15,290
$22.91 P/Share
|
|
Jun 22
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
541
-0.81%
|
$12,443
$23.41 P/Share
|